Neurocrine Biosciences Inc. (NBIX)

$ 140.62
   
  • Change Today:
    $3.27
  • 52 Week High: $155.63
  • 52 Week Low: $93.25
  • Currency: US Dollars
  • Shares Issued: 91.27m
  • Volume: 1,289,088
  • Market Cap: $12,834m
  • RiskGrade: 225
  • Beta: 0.03

NBIX Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

NBIX Fundamentals

Fundamentals data is not available for this company.

NBIX Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 3,383.63 922.88 705.76¢ 19.9 0.5 +40% n/a 0.0%
31-Dec-27 3,687.70 1,142.69 844.27¢ 16.7 0.9 +20% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

NBIX ShareCast News

No recent information was found.

NBIX Top Newspaper Links

Also 24-Jun-2006 LA Times
Also 17-May-2006 LA Times
F.D.A. Demurs on Sleep Drug by Neurocrine 17-May-2006 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

NBIX Market Data

Currency US Dollars
Share Price $ 140.62
Change Today $ 3.27
% Change 2.38 %
52 Week High $155.63
52 Week Low $93.25
Volume 1,289,088
Shares Issued 91.27m
Market Cap $12,834m
Beta 0.03
RiskGrade 225

What The Brokers Say

Strong Buy 12
Buy 11
Neutral 3
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 07-Jan-2026

Time Volume / Share Price
16:00 156,543 @ $140.62
15:59 199 @ $140.58
15:59 152 @ $140.62
15:59 100 @ $140.61
15:59 100 @ $140.60

Top of Page